title: Toxic epidermal necrolysis associated with antiepileptic drugs and cranial radiation therapy.
abstract: Case reports on the development of toxic epidermal necrolysis (TEN) associated with concurrent administration of phenytoin with cranial radiation therapy (Ahmed (2004), Criton et al. (1997), and Rzany et al. (1996)), but reports about erythema multiforme, which can develop in patients treated with levetiracetam and cranial irradiation, are very limited. This paper presents evidence that TEN may be induced by concurrent use of radiation with both phenytoin and levetiracetam. Our case is a 42-year-old male patient, a case of gliosarcoma who developed purpuric dermatitis associated with phenytoin when combined with cranial radiation therapy; although phenytoin was discontinued and switched to levetiracetam, the patient had more severe symptoms of toxic epidermal necrolysis (TEN) on levetiracetam; the patient improved with aggressive symptom management, discontinuation of antiepileptic drugs (AEDs), and holding radiotherapy. Although TEN is a rare toxicity, physicians should pay a special attention to the monitoring of brain tumor patients on antiepileptic prophylaxis during cranial irradiation; furthermore, patients should be counselled to notify their physicians if they develop any new or unusual symptoms.
authors: Pharmacy Department, National Center for Cancer Care and Research NCCCR, Hamad Medical Corporation, Doha, Qatar.
authors: Shereen
authors: S
authors: Elazzazy
authors: Taghrid
authors: T
authors: Abu Hassan
authors: Ashraf
authors: A
authors: El Seid
authors: Cicy Mary
authors: CM
authors: Jacob
references: Int J Dermatol. 2004 Jan;43(1):67-73
references: 14693027
references: Neurosurgery. 1989 Dec;25(6):976-8
references: 2601830
references: Neurology. 1997 Aug;49(2):542-6
references: 9270593
references: Clin Exp Dermatol. 1996 Mar;21(2):116-20
references: 8759197
references: South Med J. 1990 Jun;83(6):681-3
references: 2192466
references: Int J Dermatol. 1997 Dec;36(12):923-5
references: 9466199
references: Radiat Oncol. 2010 Jun 04;5:49
references: 20525360
references: Lancet. 1999 Jun 26;353(9171):2190-4
references: 10392983
references: Int J Dermatol. 1991 Oct;30(10):747-9
references: 1955236